T1	Participants 61 101	patients with chronic active hepatitis C
T2	Participants 240 283	85 patients with chronic active hepatitis C
T3	Participants 333 350	Among 55 patients
T4	Participants 351 378	who responded to interferon
T5	Participants 1093 1135	A second, independent group of 43 patients
